JP2019523226A5 - - Google Patents

Download PDF

Info

Publication number
JP2019523226A5
JP2019523226A5 JP2018564844A JP2018564844A JP2019523226A5 JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5 JP 2018564844 A JP2018564844 A JP 2018564844A JP 2018564844 A JP2018564844 A JP 2018564844A JP 2019523226 A5 JP2019523226 A5 JP 2019523226A5
Authority
JP
Japan
Prior art keywords
sbt
oil
pufa
pharmaceutical composition
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018564844A
Other languages
English (en)
Japanese (ja)
Other versions
JP7518604B2 (ja
JP2019523226A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/036330 external-priority patent/WO2017214260A1/en
Publication of JP2019523226A publication Critical patent/JP2019523226A/ja
Publication of JP2019523226A5 publication Critical patent/JP2019523226A5/ja
Application granted granted Critical
Publication of JP7518604B2 publication Critical patent/JP7518604B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018564844A 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法 Active JP7518604B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662346755P 2016-06-07 2016-06-07
US62/346,755 2016-06-07
PCT/US2017/036330 WO2017214260A1 (en) 2016-06-07 2017-06-07 Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells

Publications (3)

Publication Number Publication Date
JP2019523226A JP2019523226A (ja) 2019-08-22
JP2019523226A5 true JP2019523226A5 (cg-RX-API-DMAC7.html) 2020-07-27
JP7518604B2 JP7518604B2 (ja) 2024-07-18

Family

ID=60578981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018564844A Active JP7518604B2 (ja) 2016-06-07 2017-06-07 タキソイド薬物のナノエマルション組成物、並びに標的癌細胞及び癌幹細胞に対するその使用方法

Country Status (9)

Country Link
US (3) US10206875B2 (cg-RX-API-DMAC7.html)
EP (1) EP3463299A4 (cg-RX-API-DMAC7.html)
JP (1) JP7518604B2 (cg-RX-API-DMAC7.html)
CN (2) CN116019768A (cg-RX-API-DMAC7.html)
AU (1) AU2017277497B2 (cg-RX-API-DMAC7.html)
CA (1) CA3026412A1 (cg-RX-API-DMAC7.html)
IL (1) IL263504A (cg-RX-API-DMAC7.html)
MX (1) MX2018015112A (cg-RX-API-DMAC7.html)
WO (1) WO2017214260A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116019768A (zh) * 2016-06-07 2023-04-28 塔佳吉尼克斯公司 靶向癌细胞和癌干细胞的紫杉烷类药物的纳米乳剂组合物及其使用方法
CN112996501A (zh) * 2017-12-20 2021-06-18 塔佳吉尼克斯公司 癌症中紫杉类纳米乳剂与免疫疗法的联合
US20220226480A1 (en) * 2019-03-22 2022-07-21 Integrated Nanotherapeutics Inc. Lipid conjugate prepared from scaffold moiety
AU2020370372A1 (en) * 2019-10-25 2022-05-12 Amgen Inc. Compositions and methods for minimizing protein loss at low protein concentrations
EP4054550A4 (en) * 2019-11-05 2024-01-17 Luminus Biosciences Inc. NANOPARTICLES WITH PRODRUGS STABILIZED BY ALBUMIN FOR THE TREATMENT OF CANCER AND OTHER DISEASES
CN111004195B (zh) * 2019-12-03 2022-01-28 沈阳药科大学 卡巴他赛弱碱性衍生物及其制剂
CN114317398B (zh) * 2020-09-27 2024-03-01 中国科学院分子细胞科学卓越创新中心 Gli1和EpCAM基因共同标记的肝祖细胞群及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6426367B1 (en) * 1999-09-09 2002-07-30 Efa Sciences Llc Methods for selectively occluding blood supplies to neoplasias
CA2544128A1 (en) * 2003-10-30 2005-05-12 The Research Foundation Of State University Of New York Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
US8557861B2 (en) * 2004-09-28 2013-10-15 Mast Therapeutics, Inc. Low oil emulsion compositions for delivering taxoids and other insoluble drugs
US20070148194A1 (en) * 2005-11-29 2007-06-28 Amiji Mansoor M Novel nanoemulsion formulations
AU2009280803B2 (en) * 2008-07-23 2013-10-31 Bharat Serums And Vaccines Ltd. Stable injectable oil-in-water Docetaxel nanoemulsion
US20100021471A1 (en) * 2008-07-25 2010-01-28 Brookhaven Science Associates, Llc Carbon nanotube-based drug delivery systems and methods of making same
US20140105829A1 (en) * 2012-10-15 2014-04-17 Nemucore Medical Innovations, Inc. Therapeutic nanoemulsion formulation for the targeted delivery of docetaxel and methods of making and using the same
KR102397569B1 (ko) * 2014-06-19 2022-05-12 솔루랄 파마 에이피에스 친유성 화합물의 고형 경구 투여 형태
US10736842B2 (en) * 2014-06-25 2020-08-11 Synergia Bio Sciences Private Limited Pharmaceutical oil-in-water nano-emulsion
CN116019768A (zh) * 2016-06-07 2023-04-28 塔佳吉尼克斯公司 靶向癌细胞和癌干细胞的紫杉烷类药物的纳米乳剂组合物及其使用方法
CN112996501A (zh) * 2017-12-20 2021-06-18 塔佳吉尼克斯公司 癌症中紫杉类纳米乳剂与免疫疗法的联合

Similar Documents

Publication Publication Date Title
Panzarini et al. Novel therapeutic delivery of nanocurcumin in central nervous system related disorders
Delshadi et al. Micro and nano-encapsulation of vegetable and essential oils to develop functional food products with improved nutritional profiles
Kulawik-Pióro et al. Polymeric gels and their application in the treatment of psoriasis vulgaris: A review
Assadpour et al. Cannabidiol-loaded nanocarriers and their therapeutic applications
Leyva-Gómez et al. Approaches in polymeric nanoparticles for vaginal drug delivery: a review of the state of the art
Liu et al. Salidroside promotes peripheral nerve regeneration based on tissue engineering strategy using Schwann cells and PLGA: in vitro and in vivo
Sonu Ambwani et al. Current knowledge on nanodelivery systems and their beneficial applications in enhancing the efficacy of herbal drugs.
AU2015211711B2 (en) Orally administered agent for ruminants and ruminant feed containing same
Eskandani et al. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles
Liu et al. Advances in transdermal drug delivery systems and clinical applications in inflammatory skin diseases
Nie et al. Core/shell microspheres via coaxial electrohydrodynamic atomization for sequential and parallel release of drugs
US20250009658A1 (en) Nanoemulsion compositions of taxoid drugs, and methods for the use thereof to target cancer cells and cancer stem cells
Gadad et al. Moxifloxacin loaded polymeric nanoparticles for sustained ocular drug delivery
Ribeiro et al. Nanocarriers from natural lipids with in vitro activity against Campylobacter jejuni
Ratan et al. Nano-based formulations of curcumin: elucidating the potential benefits and future prospects in skin cancer
Jahangir et al. Transdermal nutraceuticals delivery system for CNS disease
Shen et al. Advancements in antioxidant-based therapeutics for spinal cord injury: a critical review of strategies and combination approaches
Bhushani et al. Nanodelivery of nutrients for improved bioavailability
Rajan et al. Curcumin loaded in bovine serum albumin–chitosan derived nanoparticles for targeted drug delivery
Garg et al. Resveratrol in ulcerative colitis: therapeutic mechanisms, animal model evidence and novel approaches
ES2992095T3 (es) Monoglicéridos de ácidos grasos poliinsaturados, composiciones y uso de los mismos para modular la composición de la microbiota de un sujeto
Jiang et al. Food-grade nanostructured delivery systems for oral administration of astaxanthin: Bioprocessing strategies and therapeutic applications
Karroum et al. Efficacy and safety of sulforaphane-loaded emulsomes as tested on MCF7 and MCF10A cells
JP2021517906A5 (cg-RX-API-DMAC7.html)
Khongkaew et al. Development and characterization of stingless bee propolis properties for the development of solid lipid nanoparticles for loading lipophilic substances